arrow_back Back Filing freshness 10-Q FY 2024 SEC EDGAR

Bespoke Extracts, Inc.

BSPK
— Price unavailable
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
14 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
51
Health
Fair
Neutral
auto_awesome

Analytical Summary

Bespoke Extracts, Inc. shows mixed fundamentals. On the positive side, Return on Common Equity (%) remains strong. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap —
Dividend Yield —
Revenue Growth 42.3% ↘
Op. Margin -89.0% ↗
ROIC 37.6% ↘
FCF / Share $-0.08 ↘
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close.

14-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.12M
↑ +42.3% —
Net Income Profit after all expenses
$-1.04M
↑ +30.0% —
Operating Margin Operating profit as % of sales
-89.0%
↑ +52.5% 2th
FCF / Share Free cash flow per share
$-0.08
↓ -107.0% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
3
Returns
96
Cash Quality ↑
55

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 14 years · 60 quarters